You are viewing the site in preview mode
Skip to main content
|
Characteristic
|
Insufficiency (n = 30)
|
No insufficiency (n = 55)
|
χ2 (t test)
|
P
|
|---|
|
Sex
| | | | |
|
Male
|
28
|
42
|
3.846
|
0.05
|
|
Female
|
2
|
13
| | |
|
HBsAg
| | | | |
|
Positive
|
20
|
36
|
0.013
|
0.91
|
|
Negative
|
10
|
19
| | |
|
Tumour number
| | | | |
|
Single
|
18
|
34
|
0.027
|
0.869
|
|
Multiple
|
12
|
21
| | |
|
Preoperative parameter
|
|
Age (year)
|
43.47 ± 9.09
|
45.38 ± 12.67
|
0.731
|
0.467
|
|
Platelet count (109/L)
|
243.08 ± 95.26
|
271.44 ± 79.10
|
1.390
|
0.171
|
|
Total bilirubin (μmol/l)
|
16.51 ± 6.88
|
14.97 ± 13.89
|
− 0.686
|
0.495
|
|
Albumin (g/L)
|
39.62 ± 4.93
|
38.74 ± 4.26
|
− 0.824
|
0.414
|
|
ALT (IU/L)
|
49.27 ± 24.15
|
43.49 ± 27.08
|
− 1.009
|
0.317
|
|
AST (IU/L)
|
94.43 ± 84.22
|
69.29 ± 44.26
|
− 1.808
|
0.074
|
|
Prothrombin time (s)
|
13.33 ± 1.25
|
12.61 ± 1.11
|
− 2.612
|
0.012*
|
|
Alpha-foetoprotein (μg/ml)
|
821.73 ± 516.56
|
742.67 ± 1267.02
|
− 0.405
|
0.686
|
|
Body surface area (m2)
|
1.99 ± 0.15
|
1.93 ± 0.17
|
− 1.465
|
0.148
|
|
Tumour size (cm)
|
12.10 ± 2.79
|
10.98 ± 4.06
|
− 1.499
|
0.138
|
|
Remnant liver volume (ml)
|
489.89 ± 177.39
|
586.16 ± 226.31
|
2.164
|
0.034*
|
|
SRLV (ml/m2)
|
238.25 ± 62.14
|
305.85 ± 103.35
|
3.762
|
0.000**
|
|
Child–Pugh classification
| | | | |
|
A
|
22
|
49
|
2.452
|
0.117
|
|
B
|
8
|
6
| | |
|
Intraoperative parameter
|
|
Blood loss (ml)
|
753.33 ± 623.52
|
687.27 ± 667.72
|
− 0.455
|
0.651
|
|
Postoperative parameter
|
|
Tumour capsule
| | | | |
|
Yes
|
25
|
49
|
0.174
|
0.676
|
|
No
|
5
|
6
| | |
|
Macrovascular invasion
| | | | |
|
Yes
|
26
|
39
|
2.679
|
0.102
|
|
No
|
4
|
16
| | |
|
Hepatic fibrosis stage
| | |
6.863
|
0.032*
|
|
No significant fibrosis
|
7
|
24
| | |
|
Severe fibrosis
|
7
|
17
| | |
|
Cirrhosis
|
16
|
14
| | |
|
Hospital stay (days)
|
27.37 ± 7.78
|
25.51 ± 5.39
|
− 1.785
|
0.069
|
- Values are n (%) or mean ± SD, unless otherwise noted, *p < 0.05, **p < 0.01
- HBsAg hepatitis B surface antigen, ALT alanine transaminase, AST aspartate aminotransferase, BSA body surface area, SRLV standard remnant liver volume
